| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/15/2001 | WO2001011018A2 Avian blastodermal cell lines |
| 02/15/2001 | WO2001011011A2 Multipotent adult stem cells and methods for isolation |
| 02/15/2001 | WO2001011010A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 02/15/2001 | WO2001011007A2 Bioartificial device for propagation of tissue, preparation and uses thereof |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010903A2 Proteases and protease inhibitors |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010899A2 Treatment of liver disease and injury with cxc chemokines |
| 02/15/2001 | WO2001010888A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/15/2001 | WO2001010479A1 Tissue substitute and method for the production thereof |
| 02/15/2001 | WO2001010444A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | WO2001010203A2 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 02/15/2001 | WO2001010199A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | WO2000069884A3 Compositions isolated from skin cells and methods for their use |
| 02/15/2001 | WO2000068687A3 Methods of identifying therapeutic compounds in a genetically defined setting |
| 02/15/2001 | WO2000068385A3 Novel nucleic acids and proteins with growth hormone activity |
| 02/15/2001 | WO2000068384A3 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000068370A3 ib00180US MAIS |
| 02/15/2001 | WO2000066714A3 Shiga-like toxin as an enriching and purging agent |
| 02/15/2001 | WO2000066709A3 Zymogen activation system |
| 02/15/2001 | WO2000066158A3 Use of cytokines and mitogens to inhibit pathological immune responses |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000064946A3 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 02/15/2001 | WO2000063403A3 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/15/2001 | WO2000059933A3 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000052143A3 The isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression |
| 02/15/2001 | WO2000052137A3 Plant ligand-gated ion channels |
| 02/15/2001 | WO2000050049A3 Artificial salivary gland |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000047129A3 Microfabricated membranes and matrices |
| 02/15/2001 | WO2000044908A3 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | WO2000032761A8 Ethylene-response-factor1 (erf1) in plants |
| 02/15/2001 | WO1999057128A8 Optimization of pest resistance genes using dna shuffling |
| 02/15/2001 | WO1999046366A8 Uses for humane non-autologous mesenchymal stem cells |
| 02/15/2001 | DE19937102A1 Gewebeersatz und Verfahren zu seiner Herstellung Tissue replacement and process for its preparation |
| 02/15/2001 | CA2852534A1 Multipotent adult stem cells and methods for isolation |
| 02/15/2001 | CA2388341A1 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381607A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
| 02/15/2001 | CA2381455A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 02/15/2001 | CA2381399A1 Avian blastodermal cell lines |
| 02/15/2001 | CA2381396A1 Polynucleotides and polypeptides encoded thereby |
| 02/15/2001 | CA2381325A1 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | CA2381293A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | CA2381292A1 Multipotent adult stem cells and methods for isolation |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381173A1 Recombinant stable cell clone, its production and use thereof |
| 02/15/2001 | CA2379166A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| 02/15/2001 | CA2379165A1 Chimeric proteins |
| 02/15/2001 | CA2378787A1 Method of making plant artificial chromosomes |
| 02/15/2001 | CA2378481A1 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | CA2378292A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | CA2374745A1 Proteases and protease inhibitors |
| 02/15/2001 | CA2373814A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/14/2001 | EP1076089A1 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 02/14/2001 | EP1075532A1 Partially deleted adenoviral vectors |
| 02/14/2001 | EP1075531A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
| 02/14/2001 | EP1075530A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
| 02/14/2001 | EP1075529A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 02/14/2001 | EP1075528A1 Endothelin-converting-enzyme like protein |
| 02/14/2001 | EP1075524A2 Attenuated influenza viruses |
| 02/14/2001 | EP1075522A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 02/14/2001 | EP1075518A2 Human transcriptional regulator molecules |
| 02/14/2001 | EP1075517A1 Chimeric receptors |
| 02/14/2001 | EP1075514A1 Modifying the expression of the fsh beta gene by homologous recombination |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075494A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075486A1 Method of treating bladder and lower urinary tract syndromes |
| 02/14/2001 | EP0851932B1 Plasmid stabilization |
| 02/14/2001 | EP0849990B1 Quiescent cell populations for nuclear transfer |
| 02/14/2001 | EP0683232B1 Process for producing taxane diterpene and method of harvesting cultred cell capable of producing taxane diterpene in high yield |
| 02/14/2001 | EP0576590B1 Response element compositions and assays employing same |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284131A Human tyroid protein ZSIG45 and data encoding same |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1284128A Sex-speific insemination of mammals with low number of sperm cells |
| 02/14/2001 | CN1284083A Tumor antigen peptide derivatives |
| 02/14/2001 | CN1283691A Cell culture method for tobacco for producing nicotine |
| 02/13/2001 | US6188965 Apparatus and method for automated protein design |
| 02/13/2001 | US6187996 Plant promoter comprising a G-box element, GCCACGTGCC or GCCACGTGAG, and an application thereof |
| 02/13/2001 | US6187995 Method for producing disease resistant plant with thionin gene from Avena sativa |
| 02/13/2001 | US6187993 Transgenic animals as model of psoriasis |
| 02/13/2001 | US6187991 Transgenic animal models for type II diabetes mellitus |
| 02/13/2001 | US6187908 Tubby 2 polypeptides |
| 02/13/2001 | US6187748 Treatment and prevention of hiv |
| 02/13/2001 | US6187732 The variant cellulases have replacements at sensitive residues to improve stability and/or performance. |
| 02/13/2001 | US6187564 Nucleotide sequences coding a fusion protein; for the proliferation, differentiation and activation of hematopoietic stem cells; for treatment of cancers; anticarcinogenic agents |
| 02/13/2001 | US6187562 Polynucleotides encoding human sphingosine Lyase |
| 02/13/2001 | US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents |
| 02/13/2001 | US6187560 Nucleotide sequences coding mitochondrial polypeptide; for the treatment of dietetics, diabetes, hyperlipidemia and weight defects |
| 02/13/2001 | US6187546 From fecal stools; cooling to freezing point, removal cells |
| 02/13/2001 | US6187545 Oligonucleotide sequences associated with the suppression of the activity of phosphenolpyruvate carboxykinase |
| 02/13/2001 | US6187308 Ameliorating an immune response disorder. |
| 02/13/2001 | US6187307 Cancer immunotherapy with semi-allogeneic cells |